BioSpace News Archive

Alvotech and Fuji Pharma recently announced an exclusive agreement for development and commercialization of biosimilars in Japan.

Love the holidays, hate the weight gain? Well, it’s a new year and there’s no better time to get back on track. And it may be easier than you think. A new survey fielded by Today’s Dietitian on behalf of Sunshine Health Studios found that over 94% of registered dietitians (RDs) say that health and fitness tracking apps increase weight loss success

Precision Medicine Group, Inc. (Precision) today announced it has acquired Stern Investor Relations, Inc. (Stern IR), a leading investor relations firm for entrepreneurial biotechnology and healthcare companies.

Henry Schein, Inc. (Nasdaq: HSIC) and CareCredit, a Synchrony (NYSE:SYF) solution and a leading provider of patient financing, today announced the integration of CareCredit’s financing tool into Henry Schein’s dental and veterinary practice management software solutions.

Firm closes $600 million primary biotech fund, $100 million Canadian companion fund

TITAN Medical Inc. (TSX:TMD) (Nasdaq:TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces seven new patent grants and notices of allowance related to its single-port robotic surgery technology, including patents covering multi-articulating instruments, robotic system control and user interfaces.

Diabeloop will present its plan to adapt its machine-learning adult diabetes management system to children.

Mr. Soni is a highly accomplished senior finance executive with extensive experience in the life sciences industry.

These regulations will protect Canadian families by making the food system even safer by focusing on prevention and allowing for faster removal of unsafe food from the marketplace.

Dr. Dupont, former Vice President in the Oncology Development Group at Genentech/Roche, will lead company’s clinical development